In addition, while CXCL10 was upregulated in the discovery cohort, it was downregulated in the validation cohort, indicating the need for further research into the mechanisms of CXCL10 and CCNB1 in BPD. This evidence concerns the gene CXCL10 and bronchopulmonary dysplasia.